CIVIL-LAW RELATIONS CONNECTED WITHN USING OF THE ELECTRONIC SIGNATURE

В статье исследуется использование электронной подписи в гражданско-правовых отношениях, а также гражданско-правовые отношения по ее получению. Сделаны выводы о том, что электронная подпись может использоваться в разных видах гражданских правоотношений. Перспективными для расширения ее использования являются договорные, вещные и корпоративные отношения. Отношения по поводу ее получения в удостоверяющем центре опосредуются договором оказания услуг. Выявлены практические ситуации, свидетельствующие о недостатках процедуры получения и использования электронной подписи. Исследованы изменения законодательства, которые ужесточают требования к удостоверяющим центрам и совершенствуют процедуру получения электронной подписи в целях устранения злоупотреблений по ее использованию.The article examines using of an electronic signature in various types of civil law relations and civil law relations on receiving of an electronic signature. Conclusions are drawn that the electronic signature can be used in various types of civil law relations. Contractual, property and corporate relations are promising for the development of its use. Relations on receiving of the electronic signature in the certification center are mediated by a service agreement. Practical situations have been identified that testify to the shortcomings of the procedure for obtaining and using the electronic signature. Legislative changes are studied that tighten the requirements for certification centers and improve the procedure for obtaining the electronic signature to eliminate abuses in its use

Metabolic and Body Composition Changes in Ice Hockey Players Using an Ergogenic Drug (Cytoflavin)

Background and objectives: In ice hockey, the major physical workload comes from acceleration in all planes of motion and transitions between skating trajectories. Hockey players’ anthropometric characteristics correlate with performance. In team sports, the use of ergogenic drugs for recovery is relevant to avoid athletes’ overtraining. It is very important to protect athletes’ health and allow them to maintain high-performance levels. Cytoflavin is an ergogenic drug whose action is based on the combined effects of its active ingredients (succinic acid, inosine, nicotinamide and riboflavin), which are naturally occurring metabolites that stimulate tissue respiration. The study aimed to assess the 6-week Cytoflavin consumption effects on body composition (body weight, body mass index, body fat percentage and bioimpedance phase angle) and aerobic performance. Methods: This study included 60 male professional hockey players (aged 19 to 36 years) divided into two groups of 30 subjects: group I (body weight 87.90 ± 7.44 kg, BMI 25.86 ± 2.04 kg/m2) and group II (body weight 87.04 ± 6.22 kg, BMI 25.52 ± 2.38 kg/m2). Athletes in group I received Cytoflavin, whereas athletes in group II did not. Results: In group I, statistically significant reductions in body weight and body mass index were not observed until 14 and 35 days, respectively. In contrast, in group II, both body weight and BMI significantly decreased both times. Aerobic performance significantly increased in both groups, with significantly greater increases in group I. Conclusions: Cytoflavin can be considered an ergogenic drug that improves body composition parameters, especially in the control of weight reduction and improvement in aerobic performance